# Reference Papers

## Variants

### DEPDC5

Ishida, S., Picard, F., Rudolf, G., Noé, E., Achaz, G., Thomas, P., Genton, P., Mundwiller, E., Wolff, M., Marescaux, C., Miles, R., Baulac, M., Hirsch, E., Leguern, E., & Baulac, S. (2013). Mutations of DEPDC5 cause autosomal dominant focal epilepsies. *Nature Genetics*, 45(7), 781-786. https://doi.org/10.1038/ng.2601

Ricos, M. G., Hodgson, B. L., Pippucci, T., Saidin, A., Ong, Y. S., Heron, S. E., Licchetta, L., Bisulli, F., Bayly, M. A., Hughes, J., Baldassari, S., Palombo, F., Santucci, M., Meletti, S., Berkovic, S. F., Rubboli, G., Thomas, P. Q., Scheffer, I. E., Tinuper, P., … Dibbens, L. M. (2016). Mutations in the mammalian target of rapamycin pathway regulators NPRL2 and NPRL3 cause focal epilepsy. *Annals of Neurology*, 79(1), 120–131. https://doi.org/10.1002/ana.24547

**Why are these papers important?** 

Some variants have "uncertain significance," but point towards being the cause of focal epilepsy. 

This paper was the sole research cited into several known variants of DEPDC5, e.g. positions 214, 542, etc. https://www.uniprot.org/uniprotkb/O75140/entry under disease FFEVF1. 

**What is learned from this paper for this project?**

TBD

**Next steps for this project (if any)**

TBD